×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Hikma raising injectable opioids output to help ease shortage at U.S. hospitals
Reuters
London-listed pharmaceutical group Hikma said on Wednesday it was increasing its supply of hydromorphone to U.S. hospitals to help...
1 day ago
Attorney General Josh Stein Announces $150 Million Bipartisan Opioid Settlement in Principle with Hikma ...
NCDOJ (.gov)
For Immediate Release: Thursday, February 1, 2024. Contact: Nazneen Ahmed (919) 716-0060. (RALEIGH) Attorney General Josh Stein today announced a $150...
2 months ago
Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient
Fierce Pharma
A little more than a year after Hikma Pharmaceuticals accused Amarin of “deliberately and meticulously” hamstringing supplies of the main...
3 weeks ago
Hikma announces US launch of COMBOGESIC® IV
PR Newswire
PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the launch of COMBOGESIC® IV...
2 months ago
Pharma Hikma Reaches $150M Opioid Settlement With States
Law360
Hikma Pharmaceuticals and several attorneys general announced a $150 million agreement in principle on Thursday resolving cases brought by a...
2 months ago
Hikma appoints new President of Generics business
Sharecast.com
Hikma appoints Dr. Hafrun Fridriksdottir as President of Generics business. London, 15 April 2024 - Hikma Pharmaceuticals PLC (LSE: HIK)...
4 days ago
Hikma Pharmaceuticals Sues Lloyd's of London Over Contract Breach | New York Law Journal
Law.com
Hikma Pharmaceuticals has filed a breach-of-contract lawsuit against insurance company Lloyd's of London, claiming its insurers have failed...
7 months ago
and Hikma Sign Exclusive Licensing Agreement for Alluminox™ Platform Cancer Treatment in the Middle East and ...
Rakuten Medical
Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell targeting therapies based on its...
8 months ago
Merck’s Bridion Could Face Generic Pressure from Hikma Ahead of Patent Expiry Date
BioSpace
Despite a patent extension, Merck's muscle relaxant reversal injection is now facing potential generic competition from Hikma...
1 month ago
Hikma Pharmaceuticals PLC's (LON:HIK) institutional investors lost 5.8% over the past week but have profited from ...
Yahoo Finance
Hikma Pharmaceuticals is not owned by hedge funds. The company's largest shareholder is Darhold Ltd., with ownership of 27%. Meanwhile, the...
5 months ago